Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis.

Early diagnosis along with new drugs targeted to cancer receptors and immunocheckpoints have improved breast cancer survival. However, full remission remains elusive for metastatic breast cancer due to dose-limiting toxicities of heavily used, highly potent drug combinations such as gemcitabine and...

Full description

Saved in:
Bibliographic Details
Main Authors: Qingxin Mu, Jesse Yu, James I Griffin, Yan Wu, Linxi Zhu, Lisa A McConnachie, Rodney J Y Ho
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2020
Subjects:
R
Q
Online Access:https://doaj.org/article/cb89d7d76ccd4535a410f364e5bbf9bc
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items